non-contact marathon arrayjet microarray spotter (Arrayjet Limited)
Structured Review

Non Contact Marathon Arrayjet Microarray Spotter, supplied by Arrayjet Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-contact marathon arrayjet microarray spotter/product/Arrayjet Limited
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Multiplex Serology for Sensitive and Specific Flavivirus IgG Detection: Addition of Envelope Protein Domain III to NS1 Increases Sensitivity for Tick-Borne Encephalitis Virus IgG Detection"
Article Title: Multiplex Serology for Sensitive and Specific Flavivirus IgG Detection: Addition of Envelope Protein Domain III to NS1 Increases Sensitivity for Tick-Borne Encephalitis Virus IgG Detection
Journal: Viruses
doi: 10.3390/v16020286
Figure Legend Snippet: Production of orthoflavivirus recombinant NS1 for sensitive and specific microarray detection of orthoflavivirus IgG. ( a ) Recombinant NS1 and ( b ) recombinant EDIII of TBEV, West Nile virus (WNV) lineage 2, dengue virus (DENV) DENV 1 , DENV 2 , DENV 3 , DENV 4 , Zika virus (ZIKV), Japanese encephalitis virus (JEV) and Usutu virus (USUV) were purified and then analyzed via SDS-PAGE.
Techniques Used: Recombinant, Microarray, Virus, Purification, SDS Page
Figure Legend Snippet: Overview of serum collection used for orthoflavivirus microarray validation.
Techniques Used: Microarray, Biomarker Discovery, Enzyme-linked Immunosorbent Assay, Virus, Neutralization
Figure Legend Snippet: Validation of orthoflavivirus recombinant NS1 for sensitive and specific microarray detection of orthoflavivirus IgG. Heatmaps displaying microarray titers for the orthoflavivirus rNS1 of ( a ) orthoflavivirus negative reference sera, ( b ) WNV patients, ( d ) ZIKV patients, ( f ) DENV patients and ( h ) TBEV patients. (The color key of the titers is indicated at the bottom of each heatmap). The microarray antigens are listed on the left of each heatmap. Violin plots showing microarray titers of ( c ) WNV patients, ( e ) ZIKV patients, ( g ) DENV patients and ( i ) TBEV natural infection-positive sera against the recombinant NS1 of TBEV, DENV1, DENV2, DENV3, DENV4, ZIKV, WNV, USUV and JEV. A non-parametric t -test was performed to assess the statistical differences of paired samples. Significance is noted as ***, p < 0.001; *, p < 0.5. ( b ) Receiving operating characterization (ROC) curve was created with GraphPad Prism software (version 9.1.0).
Techniques Used: Biomarker Discovery, Recombinant, Microarray, Infection, Software
Figure Legend Snippet: ( a ) Heatmap displaying microarray titers for the orthoflavivirus rNS1 of orthoflavivirus TBEV-vaccinated patients. (The color key of the titers is indicated at the bottom of the heatmap). The microarray antigens are listed on the left of the heatmap. ( b ) Violin plot showing microarray titers of the pre-characterized TBEV, dengue virus (DENV), Zika virus (ZIKV), West Nile virus (WNV) sera and the negative orthoflavivirus sera against TBEV rEDIII. TBEV vaccinees were used as the positive control. ( c ) Heatmap displaying microarray titers for the orthoflavivirus rEDIII of orthoflavivirus TBEV-vaccinated patients. (The color key of the titers indicated at the bottom of the heatmap.) The microarray antigens are listed on the y-axis. ( d )Violin plot showing microarray titers of TBEV-vaccinated serum samples against the recombinant EDIII of TBEV, DENV1, DENV2, DENV3, DENV4, ZIKV, WNV, USUV and JEV. A non-parametric T-test was performed to assess the statistical differences of paired samples. Significance is noted as ****, p < 0.0001; **, p < 0.01; *, p < 0.5. The order of patient samples is the same for each heatmap.
Techniques Used: Microarray, Virus, Positive Control, Recombinant
Figure Legend Snippet: TBEV-infected serum samples against recombinant EDIII. ( a ) Heatmap displaying microarray titers for the orthoflavivirus rEDIII of orthoflavivirus TBEV natural infection-positive sera. (The color key of the titers is indicated at the bottom of each heatmap). The microarray antigens are listed on the y-axis. ( b ) Violin plots showing the microarray titers of TBEV natural infection-positive sera against the recombinant EDIII of TBEV, DENV1, DENV2, DENV3, DENV4, ZIKV, WNV, USUV and JEV. A non-parametric T-test was performed to assess the statistical differences of paired samples. Significance is noted as ****, p < 0.0001; ***, p < 0.001; *, p < 0.5. ( c ) Receiving operating characterization (ROC) curve was created with GraphPad Prism software (version 9.1.0). The order of patient samples is the same as in .
Techniques Used: Infection, Recombinant, Microarray, Software
Figure Legend Snippet: Evaluation of recombinant orthoflavivirus EDIII as an antigen. Heatmaps and violin plots showing the microarray titers of ZIKV-positive sera ( a , b ), DENV-positive sera ( c , d ) and WNV-positive sera ( e , f ) against the recombinant rEDIII of TBEV, DENV1, DENV2, DENV3, DENV4, ZIKV, WNV, USUV and JEV. The order of patient samples is the same as in .
Techniques Used: Recombinant, Microarray
Figure Legend Snippet: All TBEV serology results of sera ( n = 5) that tested TBEV IgG positive for rNS1 and/or rEDIII in the orthoflavivirus microarray.
Techniques Used: Microarray, Enzyme-linked Immunosorbent Assay, Infection